October 15, 2025
1 min read

AstraZeneca to spend $445M to boost production of Lokelma at Texas plant

With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the capabilities of AZ’s manufacturing facility in Coppell, Texas, which is the company’s lone site in the world that produces Lokelma.

Leave a Reply

Your email address will not be published.

Previous Story

Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis

Next Story

CDC workforce is down 33% since Trump’s start, per union

Previous Story

Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis

Next Story

CDC workforce is down 33% since Trump’s start, per union

Latest from Blog

Go toTop